COMP <GO>
MMSI vs LLY // EV/EBITDA & P/E VALUATION
Merit Medical Systems Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: MMSI 4
— LLY 10
▲ EV/EBITDA & P/E VALUATION LEADER: MMSI
LAST: $86.24 (-7.66%) • MKT CAP: $5.58B
valuation
23.1x
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
valuation
36.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMSI VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMSI | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.70% | 83.64% | -34.94 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | 32.36% | -24.56 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 23.1x | 36.4x | -13.32 | MMSI | /valuation <GO> |
| Free Cash Flow Yield | 3.87% | 2.30% | +1.57 | MMSI | /fcf-yield <GO> |
| Operating Margin | 12.20% | 40.21% | -28.01 | LLY | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 31.90% | -23.40 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 45.51% | -33.71 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 9.29 | -4.67 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.77% | -0.07 | MMSI | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.3 | 77.9 | -36.61 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.51 | +0.43 | MMSI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 40.4x | 26.3x | +14.15 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.58B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMSI REV | LLY REV | MMSI GROSS % | LLY GROSS % | MMSI FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $65.18B | 48.7% | 83.0% | $215.7M | $16.81B |
| FY 2024 | $1.36B | $45.04B | 47.4% | 81.3% | $185.7M | $8.82B |
| FY 2023 | $1.26B | $34.12B | 44.0% | 79.3% | $88.6M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMSI // BETA 0.94
LLY // BETA 0.51